NEW YORK – GE HealthCare on Tuesday said it is collaborating with University Medicine Essen to establish a Theranostics Center of Excellence that will support personalized cancer care in Germany and around the world.
The partners aim to expand production of radioisotopes and facilitate access to them, to outfit facilities with innovative technologies that will enable personalized treatment recommendations, and to support research aimed at advancing precision medicine.
The collaboration will begin with a study of GE HealthCare's total body PET/CT technology using radioactive tracers to detect cancer at earlier stages than would be possible with conventional imaging tests. The project will also evaluate the use of Single Photon Emission/Computed Tomography (SPECT/CT), which uses a radioactive tracer and a camera to produce 3D images depicting organ function, and artificial intelligence technologies to improve diagnosis and clinical and radiology workflows.
GE HealthCare will provide an Omni Legend 32cm PET/CT, a Signa PET/MR, and several SPECT/CT systems for use in the Center of Excellence. The company will also work with University Medicine Essen to expand the use of PET/CT for cancer diagnosis, therapeutic planning, and treatment response assessment.
GE HealthCare has previously collaborated with University Medicine Essen and Vanderbilt University Medical Center to validate AI models that predict patient response to immunotherapy.